San Clemente-based USGI Medical Inc. raised more than $19.5 million from equity and debt investors.
USGI makes less-invasive surgical devices for weight loss. It said that it would use the money to extend the commercial launch of its Pose device in Europe and the Middle East and start precommercialization activities for the device in the U.S.
USGI said that it has raised $36 million during the past year.
Pose is now in clinical trials, and USGI is preparing to submit an application to the Food and Drug Administration.
Existing investors contributed the equity portion of the deal, and GE Capital Healthcare Financial Services and East West Bank were involved with the debt.
